Sign In

Login

Password

Forgot Password ? Sign Up

Հորմոնային ներարգանդային պարույր (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Հորմոնային ներարգանդային պարույր" in Armenian language version.

refsWebsite
Global rank Armenian rank
15nih.gov
4th place
3rd place
14doi.org
2nd place
4th place
4archive.org
6th place
6th place
3web.archive.org
1st place
1st place
3infoforhealth.org
low place
low place
2plannedparenthood.org
low place
1,515th place
2who.int
195th place
49th place
2mirena-us.com
low place
low place
1nejm.org
2,374th place
871st place
1cdc.gov
218th place
51st place
1rexall.ca
low place
low place
1aafp.org
1,916th place
203rd place
1worldcat.org
5th place
10th place
1bayerresources.com.au
low place
5,996th place
1medicines.org.uk
3,823rd place
1,279th place
1inchem.org
4,334th place
1,756th place

aafp.org

archive.org

bayerresources.com.au

cdc.gov

doi.org

  • Winner, B; Peipert, JF; Zhao, Q; Buckel, C; Madden, T; Allsworth, JE; Secura, GM. (2012), «Effectiveness of Long-Acting Reversible Contraception», New England Journal of Medicine, 366 (21): 1998–2007, doi:10.1056/NEJMoa1110855, PMID 22621627{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Luis Bahamondes, M Valeria Bahamondes, Ilza Monteiro. (2008), «Levonorgestrel-releasing intrauterine system: uses and controversies.», Expert Review of Medical Devices, 5 (4): 437–45, doi:10.1586/17434440.5.4.437, PMID 18573044{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Petta C, Ferriani R, Abrao M, Hassan D, Rosa E Silva J, Podgaec S, Bahamondes L (2005). «Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis». Hum Reprod. 20 (7): 1993–8. doi:10.1093/humrep/deh869. PMID 15790607.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Sheng, J; Zhang, WY; Zhang, JP; Lu, D. (2009), «The LNG-IUS study on adenomyosis: a 3-year follow-up on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrheal associated with adenomyosis», Contraception, 79 (3): 189–193, doi:10.1016/j.contraception.2008.11.004{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Faundes A, Alvarez F, Brache V, Tejada A (1988). «The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation». Int J Gynaecol Obstet. 26 (3): 429–33. doi:10.1016/0020-7292(88)90341-4. PMID 2900174.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Marjoribanks J, Lethaby A, Farquhar C (2006). Marjoribanks, Jane (ed.). «Surgery versus medical therapy for heavy menstrual bleeding». Cochrane Database Syst Rev (2): CD003855. doi:10.1002/14651858.CD003855.pub2. PMID 16625593.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Sivin I, Stern J, Coutinho E, և այլք: (1991 թ․ նոյեմբեր). «Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS». Contraception. 44 (5): 473–80. doi:10.1016/0010-7824(91)90149-a. PMID 1797462.
  • Truitt S, Fraser A, Grimes D, Gallo M, Schulz K (2003). Lopez, Laureen M (ed.). «Combined hormonal versus nonhormonal versus progestin-only contraception in lactation». Cochrane Database Syst Rev (2): CD003988. doi:10.1002/14651858.CD003988. PMID 12804497.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Schiappacasse V, Díaz S, Zepeda A, Alvarado R, Herreros C (2002). «Health and growth of infants breastfed by Norplant contraceptive implants users: a six-year follow-up study». Contraception. 66 (1): 57–65. doi:10.1016/S0010-7824(02)00319-0. PMID 12169382.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Hidalgo, M; Bahomondes, L; Perrottie, M; Diaz, J; Dantas-Monterio, C; Petta, CA. (2002), «Bleeding Patterns and clinical performance of the levonorgestrel-releasing intrauterine device (Mirena) up to two years», Contraception, 65 (2): 129–132, doi:10.1016/S0010-7824(01)00302-X, PMID 11927115{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Rönnerdag M, Odlind V (1999). «Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use». Acta Obstet Gynecol Scand. 78 (8): 716–21. doi:10.1034/j.1600-0412.1999.780810.x. PMID 10468065.
  • Mohllajee, AP; Curtis, KM; Herbert, PB. (2006), «Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review», Contraception, 73 (2): 145–153, doi:10.1016/j.contraception.2005.08.007{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Mansour, D; Gemzell-Danielsson, K; Inki, Pirjo; Jensen, JT. (2011), «Fertility after discontinuation of contraception: a comprehensive review of the literature», Contraception, 84 (5): 465–477, doi:10.1016/j.contraception.2011.04.002, PMID 22018120{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Randic, L; Vlasic, S; Matrljan, I; Waszak, C (1985), «Return to fertility after IUD removal for planned pregnancy», Contraception, 32 (3): 253–259, doi:10.1016/0010-7824(85)90048-4{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)

inchem.org

infoforhealth.org

medicines.org.uk

  • «Mirena». BayerUK. 2013 թ․ հունիսի 11. Վերցված է 2015 թ․ հունիսի 18-ին.

mirena-us.com

hcp.mirena-us.com

mirena-us.com

  • [1], Bayer Pharmaceuticals.

nejm.org

  • Winner, B; Peipert, JF; Zhao, Q; Buckel, C; Madden, T; Allsworth, JE; Secura, GM. (2012), «Effectiveness of Long-Acting Reversible Contraception», New England Journal of Medicine, 366 (21): 1998–2007, doi:10.1056/NEJMoa1110855, PMID 22621627{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Winner, B; Peipert, JF; Zhao, Q; Buckel, C; Madden, T; Allsworth, JE; Secura, GM. (2012), «Effectiveness of Long-Acting Reversible Contraception», New England Journal of Medicine, 366 (21): 1998–2007, doi:10.1056/NEJMoa1110855, PMID 22621627{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Luis Bahamondes, M Valeria Bahamondes, Ilza Monteiro. (2008), «Levonorgestrel-releasing intrauterine system: uses and controversies.», Expert Review of Medical Devices, 5 (4): 437–45, doi:10.1586/17434440.5.4.437, PMID 18573044{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Petta C, Ferriani R, Abrao M, Hassan D, Rosa E Silva J, Podgaec S, Bahamondes L (2005). «Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis». Hum Reprod. 20 (7): 1993–8. doi:10.1093/humrep/deh869. PMID 15790607.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Faundes A, Alvarez F, Brache V, Tejada A (1988). «The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation». Int J Gynaecol Obstet. 26 (3): 429–33. doi:10.1016/0020-7292(88)90341-4. PMID 2900174.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Marjoribanks J, Lethaby A, Farquhar C (2006). Marjoribanks, Jane (ed.). «Surgery versus medical therapy for heavy menstrual bleeding». Cochrane Database Syst Rev (2): CD003855. doi:10.1002/14651858.CD003855.pub2. PMID 16625593.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Sivin I, Stern J, Coutinho E, և այլք: (1991 թ․ նոյեմբեր). «Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS». Contraception. 44 (5): 473–80. doi:10.1016/0010-7824(91)90149-a. PMID 1797462.
  • Truitt S, Fraser A, Grimes D, Gallo M, Schulz K (2003). Lopez, Laureen M (ed.). «Combined hormonal versus nonhormonal versus progestin-only contraception in lactation». Cochrane Database Syst Rev (2): CD003988. doi:10.1002/14651858.CD003988. PMID 12804497.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Schiappacasse V, Díaz S, Zepeda A, Alvarado R, Herreros C (2002). «Health and growth of infants breastfed by Norplant contraceptive implants users: a six-year follow-up study». Contraception. 66 (1): 57–65. doi:10.1016/S0010-7824(02)00319-0. PMID 12169382.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Hidalgo, M; Bahomondes, L; Perrottie, M; Diaz, J; Dantas-Monterio, C; Petta, CA. (2002), «Bleeding Patterns and clinical performance of the levonorgestrel-releasing intrauterine device (Mirena) up to two years», Contraception, 65 (2): 129–132, doi:10.1016/S0010-7824(01)00302-X, PMID 11927115{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Rönnerdag M, Odlind V (1999). «Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use». Acta Obstet Gynecol Scand. 78 (8): 716–21. doi:10.1034/j.1600-0412.1999.780810.x. PMID 10468065.
  • Bahamondes L, Hidalgo M, Petta CA, Diaz J, Espejo-Arce X, Monteiro-Dantas C. (2003), «Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant», J. Reproduc. Med., 48 (8): 637–640, PMID 12971147{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Nijhuis J, Schijf C, Eskes T (1985). «The lost IUD: don't look too far for it». Ned Tijdschr Geneeskd. 129 (30): 1409–10. PMID 3900746.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Kaplan N (1976). «Letter: Lost IUD». Obstet Gynecol. 47 (4): 508–9. PMID 1256735.
  • Mansour, D; Gemzell-Danielsson, K; Inki, Pirjo; Jensen, JT. (2011), «Fertility after discontinuation of contraception: a comprehensive review of the literature», Contraception, 84 (5): 465–477, doi:10.1016/j.contraception.2011.04.002, PMID 22018120{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Malik, S (2013 թ․ հունվար). «Levonorgestrel-IUS system and endometrial manipulation». Journal of mid-life health. 4 (1): 6–7. PMID 23833526.

plannedparenthood.org

  • «IUD». Planned Parenthood. Վերցված է 2015 թ․ հունիսի 18-ին.
  • «Understanding IUDs». Planned Parenthood. 2005 թ․ հուլիս. Արխիվացված է օրիգինալից 2006 թ․ հոկտեմբերի 12-ին. Վերցված է 2006 թ․ հոկտեմբերի 8-ին.

rexall.ca

  • «Mirena». MediResource Inc. Վերցված է 2015 թ․ հունիսի 18-ին.

web.archive.org

who.int

worldcat.org

  • Dean, Gillian; Schwarz, Eleanor Bimla (2011). «Intrauterine contraceptives (IUCs)». In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. էջեր 147–191. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. p.150:

    Mechanism of action
    Although the precise mechanism of action is not known, currently available IUCs work primarily by preventing sperm from fertilizing ova.26 IUCs are not abortifacients: they do not interrupt an implanted pregnancy.27 Pregnancy is prevented by a combination of the "foreign body effect" of the plastic or metal frame and the specific action of the medication (copper or levonorgestrel) that is released. Exposure to a foreign body causes a sterile inflammatory reaction in the intrauterine environment that is toxic to sperm and ova and impairs implantation.28,29 The production of cytotoxic peptides and activation of enzymes lead to inhibition of sperm motility, reduced sperm capacitation and survival, and increased phagocytosis of sperm.30,31… The progestin in the LNg IUC enhances the contraceptive action of the device by thickening cervical mucus, suppressing the endometrium, and impairing sperm function. In addition, ovulation is often impaired as a result of systemic absorption of levonorgestrel.23
    p. 162:
    Table 7-1. Myths and misconceptions about IUCs
    Myth: IUCs are abortifacients. Fact: IUCs prevent fertilization and are true contraceptives.